Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York

Health, Fitness & Food

New York State Attorney General, Letitia James, speaks during a news conference, to announce criminal justice reform in New York City, U.S., May 21, 2021.
Brendan McDermid | Reuters

New York Attorney General Letitia James announced on Saturday that Johnson & Johnson has agreed to halt sales of opioids nationwide in a $230 million settlement with New York state.

As part of the settlement, the company will resolve opioids-related claims and allocate payments over nine years. It could also pay $30 million more in the first year if the state executive chamber signs into law new legislation creating an opioid settlement fund, according to the press release from James’ office.

“The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” James said in a statement.

“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country,” she said.

This is breaking news. Please check back for updates.

Products You May Like

Articles You May Like

Aquestive Therapeutics Resubmits New Drug Application for Libervant (diazepam) Buccal Film
Researchers develop ovarian tumor microenvironment-chip to test novel ways to treat the disease
Injecting Cocaine Into Your Spine for Science
Join us at Wellbeing by the Lakes!
Watch: More long covid cases seen in kids

Leave a Reply

Your email address will not be published. Required fields are marked *